• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem High Test Results (2457)
Patient Problems Headache (1880); Inflammation (1932); Brain Injury (2219)
Event Date 12/28/2014
Event Type  malfunction  
Event Description
Caller reporting discrepant high inratio values (b)(6) 2014, inratio 6.2, lab 3.2, tests performed within three hours.(b)(6) 2015, inratio 5.7.(b)(6) 2015, lab 3.2, one day between tests performed on (b)(6) 2015.Patient's therapeutic range 2.5 - 3.5.No coumadin dosage changes between receiving the inratio result and the corresponding lab result.Patient self tester went to the er on (b)(6) 2015 after experiencing severe headaches on (b)(6) 2015.Inr (venous draw) was taken upon admittance.Patient admitted and diagnosed with brain inflammation.Patient hospitalized for one week during which the patient was taken off coumadin and placed on lovenox.Patient underwent brain surgery for the inflammation during hospitalization, no exact date available.Patient was released to home 1 week after admittance, patient currently comfortable at home.Requested discharge diagnosis.Per patient, no discharge diagnosis available.Patient stated that physician had stated the inflammation was consistent with severe trauma to the head (a contusion), however patient states that no trauma was experienced prior to hospitalization.Patient currently taking lovenox but will be bridged back to coumadin shortly.No additional information available.
 
Manufacturer Narrative
Investigation conclusion: it is indicated that product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.Retain strip testing results met both accuracy and repeatability criteria.The products performed as expected and no product deficiencies were observed.The manufacturing records for the lot were reviewed.The non-conformance associated with this lot was not relevant to the initial complaint and does not affect product performance.Root cause could not be determined from the information provided by the customer.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
9975 summers ridge road
san diego CA 92121
Manufacturer Contact
ya-ling king
9975 summers ridge road
san diego, CA 92121
8588052084
MDR Report Key4504615
MDR Text Key20374067
Report Number2027969-2015-00097
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/30/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number354045
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/30/2015
Initial Date FDA Received02/10/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
COUMADIN TAKEN OFF (B)(6) WILL BE BRIDGED BACK; LOVENOX; INRATIO MONITOR SERIAL #(B)(4)
-
-